PI3K/AKT/mTOR inhibition may decrease tumor cell proliferation, and enhance tumor immune surveillance by the secretion of immunosuppressive cytokines, the recruitment of intratumoral MDSCs, and the development of memory T cells. This evidence concerns the gene MTOR and neoplasm.